ClinicalTrials.gg
CompletedNCT01199601Updated May 17, 2017Results posted

Blood-borne Infection Screening in an Afghan Antenatal Population

An interventional study of Concentrated postpartum counseling in Viral Hepatitis B, Contraception and Breast Feeding, Exclusive, sponsored by Columbia University. Completed at 1 site in Afghanistan. Open to participants aged 14 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-17.

Sponsored by Columbia University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,291
Allocation
Randomized
Ages
14 Years to 65 Years
Sex
All
01

Study summary

Baseline information indicates there are measurable levels of hepatitis B SAg and low utilization of postpartum contraception, correct breastfeeding practices, or adherence to infant vaccination schedules in Kabul, Afghanistan. This intervention will randomize hospitals to assess the following aims:

Aim 1: To determine whether the re-training and assignment of health care providers dedicated to intrapartum rapid testing and post-partum counseling will positively impact maternal and neonatal health indicators as compared to utilization of existing health providers for these services among women delivering in publish health maternity hospitals in Kabul, Afghanistan.

Aim 2: To assess whether patients randomized to the intervention and their spouses perceive value in concentrated post-partum counseling.

Aim 3: To investigate whether an intervention providing immediate post-partum provision of a long-acting family planning method would be feasible and acceptable to both men and women in Kabul, Afghanistan.

Read the detailed description

Outcomes are assessed through questionnaire responses and inspection of vaccination cards at six month intervals by trained study staff through one year total study time. Differences between groups will be assessed with generalized linear mixed modeling. Information obtained to address Aim 3 will be gathered at the 12 month follow-up and analyzed with simple proportions and Chi-square test to assess differences between sexes and other socioeconomic indicators.

02

Conditions studied

  • Viral Hepatitis B
  • Contraception
  • Breast Feeding, Exclusive
  • Effects of; Lack of Care of Infants
03

In context

Hepatitis B

1,045 studies on the registry are indexed under Hepatitis B; 139 are open to participants now.

This study's enrollment of 1,291 is above the median of 147 across 756 interventional studies indexed under Hepatitis B.

Browse Hepatitis B studies →

Lead sponsor

Columbia University is the lead sponsor of 1,136 studies on the registry; 195 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 148 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • admitted for obstetric care
  • Dari or Pashto speaking
  • not previously participated in the study
  • in medically stable condition
  • accompanied by and have approval of a spouse
  • able to provide

Male participants must be the confirmed spouses of the female participants, have a working telephone, and able to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • medically unstable or imminently delivering (complete cervical dilation)
  • husband unavailable or does not approve participation
  • unable to provide consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,291 participants (actual)

Study arms

  • Experimental
    Concentrated postpartum counseling

    Women randomized to receiving concentrated postpartum counseling from the retrained provider.

    Behavioral: Concentrated postpartum counseling

  • No intervention
    Routine postpartum counseling

    Women receiving intra-partum testing and post-partum counseling from existing cadres of hospital providers at standard of care.

Interventions

  • BehavioralConcentrated postpartum counseling

    Intrapartum testing and concentrated postpartum counseling for the female patient from a retrained provider focusing on correct breastfeeding practices, postpartum contraception, and infant vaccination.

06

What researchers measure

Primary outcomes

  1. Utilization of Postpartum Contraception

    Determine whether the re-training and assignment of healthcare providers dedicated to intrapartum rapid testing and intensive post-partum counseling will positively impact postpartum contraceptive use as compared to any counseling provided by existing health providers for these services among women delivering in public health maternity hospitals in Kabul, Afghanistan.

    Time frame: 12 months

Secondary outcomes

  1. Correct Breastfeeding Practices to 1 Year

    Assess whether patients randomized to the intervention exhibit correct breastfeeding practices (a composite variable in which exclusive breastfeeding occurs to 6 months and continued complementary breastfeeding continues to 12 months) after receiving concentrated postpartum counseling compared to women receiving standard of care.

    Time frame: 12 months

  2. Completion of 9 Month Measles-mumps-rubella Vaccination on Time.

    Assess whether patients randomized to the intervention were more likely to have children receiving the measles-mumps-rubella vaccination at 9 months of age after receiving concentrated postpartum counseling compared to women receiving standard of care.

    Time frame: 12 months

07

Results

Posted Mar 28, 2014

Participant flow

Women in active labor able to provide consent recruited by random number designation at four Kabul public maternity hospitals following admission. Recruitment occurred from June 2008 through January 2009.

Participant flow — Overall Study
MilestoneCounseling Existing ProvidersCounseling, Retrained Provider
Started422422
Completed353344
Not completed6978
Withdrew: Lost to follow-up4766
Withdrew: Withdrawal by subject153
Withdrew: Insecurity prevented staff interviewing.79

Outcome measures

PrimaryUtilization of Postpartum Contraception

Determine whether the re-training and assignment of healthcare providers dedicated to intrapartum rapid testing and intensive post-partum counseling will positively impact postpartum contraceptive use as compared to any counseling provided by existing health providers for these services among women delivering in public health maternity hospitals in Kabul, Afghanistan.

Time frame:
12 months
Reported as:
Number · participants
Utilization of Postpartum Contraception
participantsCounseling Existing ProvidersCounseling, Retrained Provider
Utilization of Postpartum Contraception199213
Statistical analysis
  • Counseling Existing Providers vs Counseling, Retrained Provider · Regression, Linear · p = <0.05 · Incidence rate ratio: 1.12 · 95% CI 1.02 to 1.23Information provided for crude analysis results; adjustment for significant baseline differences between groups did not change results substantially.
SecondaryCorrect Breastfeeding Practices to 1 Year

Assess whether patients randomized to the intervention exhibit correct breastfeeding practices (a composite variable in which exclusive breastfeeding occurs to 6 months and continued complementary breastfeeding continues to 12 months) after receiving concentrated postpartum counseling compared to women receiving standard of care.

Time frame:
12 months
Reported as:
Number · participants
Correct Breastfeeding Practices to 1 Year
participantsCounseling Existing ProvidersCounseling, Retrained Provider
Correct Breastfeeding Practices to 1 Year198240
Statistical analysis
  • Counseling Existing Providers vs Counseling, Retrained Provider · Regression, Linear · p = <0.05 · Incidence rate ratio: 1.10 · 95% CI 1.02 to 1.18Outcomes were assessed by crude and adjusted risk ratios with log-binomial generalized linear models.
SecondaryCompletion of 9 Month Measles-mumps-rubella Vaccination on Time.

Assess whether patients randomized to the intervention were more likely to have children receiving the measles-mumps-rubella vaccination at 9 months of age after receiving concentrated postpartum counseling compared to women receiving standard of care.

Time frame:
12 months
Reported as:
Number · participants
Completion of 9 Month Measles-mumps-rubella Vaccination on Time.
participantsCounseling Existing ProvidersCounseling, Retrained Provider
Completion of 9 Month Measles-mumps-rubella Vaccination on Time.211235
Statistical analysis
  • Counseling Existing Providers vs Counseling, Retrained Provider · Regression, Logistic · p = 0.05 · Odds ratio (or): 1.13 · 95% CI 1.01 to 1.25The crude analysis result is provided as the odds ratio did not change substantially when adjusted for possible confounders.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Counseling Existing Providers—0/422 (0%)0/422 (0%)
Counseling, Retrained Provider—0/422 (0%)0/422 (0%)

Baseline characteristics

The 1291 reflects the husbands interviewed at 12 months (n=447). The husbands were not analyzed as part of the RCT.

Age, Categorical
Age, Categorical(Participants)Counseling Existing ProvidersCounseling, Retrained ProviderTotal
<=18 years343165
Between 18 and 65 years388391779
>=65 years000
Age, Continuous
Age, Continuous(years)Counseling Existing ProvidersCounseling, Retrained ProviderTotal
Mean25.1 ± 5.624.8 ± 5.524.9 ± 5.5
Sex: Female, Male
Sex: Female, Male(Participants)Counseling Existing ProvidersCounseling, Retrained ProviderTotal
Female422422844
Male000
Region of Enrollment
Region of Enrollment(participants)Counseling Existing ProvidersCounseling, Retrained ProviderTotal
Afghanistan422422844
08

Study locations

1 site
  • Maternity Hospitals
    Kabul, Afghanistan
09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01199601
Responsible party
Sponsor
First posted
Sep 13, 2010
Start date
Jun 2008
Primary completion
May 2010
Completion
May 2010
Results posted
Mar 28, 2014
Last update
May 17, 2017

Study contacts

Catherine Todd, MD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion